Patients Know Best
$14.5M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Patients Know Best is currently valued at N/A. The company has raised a total of $46.1M in funding.
Investment Perspective
Patients Know Best's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Patients Know Best Worth in 2025?
As of 2025, Patients Know Best is valued at N/A. This valuation positions Patients Know Best as one of the leading private companies in the sector.
Patients Know Best Valuation History
Patients Know Best's funding history demonstrates steady growth and investor confidence.
How Patients Know Best Valuation is Determined
Private company valuations like Patients Know Best's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Patients Know Best Valuation FAQs
Is Patients Know Best profitable?
Patients Know Best has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Patients Know Best's valuation compare to competitors?
Patients Know Best is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Patients Know Best IPO?
Patients Know Best has not announced plans for an initial public offering. Until an IPO, investors can access Patients Know Best shares through secondary market platforms.